There is certainly lots of excitement and news flying around in the cannabis space as we inch ever so close to the first day of legalized recreational use in Canada on October 17th, 2018. Perhaps you may be overwhelmed with all the news and buzz within the industry and some of the latest happenings. Today, we would like to go over what can be considered a pivotal news release that Organigram put out this September in regards to their investment in Hyasynth Biologicals Inc. To see the press release from the company please click here:
Why is this a game changer?
The technology behind the investment in Hyasynth will allow for Organigram to produce pure cannabinoids at a fraction of the current cost that they are capable of doing via the traditional route of growing cannabis for 10-15 weeks and then extracting the cannabinoids via ethanol or CO2 methodologies. Organigram’s CEO Greg Engel said recently that "Hyasynth's technology offers us access to the future of cannabinoid production today." It is understood that with the disruptive technology that Hyasynth brings to the table that Organigram will now be able to produce pure THC, CBG, and CBD as well as other sub cannabinoids at pennies on the dollar versus plant-based growing methodologies currently in place. On top of that, Engel says that this can be infinitely scalable relative to the 100,000 and 1,000,000 square foot cannabis facilities we are seeing today.
Invests In Their Future With
Hyasynth
Biologicals
Organigram
BY Ryan Hum
23